Monthly Archives: November 2021

Health

Butterfly Medical Receives CE Approval for its Next Generation Medical Device to Noninvasively Treat BPH Patients

Leave a comment


Butterfly Medical – Changing the treatment paradigm for BPH patients

The minimally invasive, non-surgical device market for BPH treatment is a very active market with significant M&A deals in the range of a few hundred million to one billion dollars. Butterfly’s innovative solution has great potential to become a leading solution for this market


YOKNEAM, Israel (PRWEB)

Butterfly Medical, today announced that its next generation device to reduce or eliminate benign prostatic hyperplasia (BPH) symptoms has obtained European CE Mark approval.

BPH is a condition where the prostate enlarges and is highly prevalent in men, 50+ years old. Its symptoms often include problems urinating, urgency to urinate, getting-up during the night, as well as sexual dysfunction all having a significant negative impact on quality of life. Medication is often the first line of therapy, but relief can be inadequate and temporary, with patients needing invasive surgical procedures.

Butterfly’s next generational device provides a much-needed simple, fast and minimally invasive treatment option, by focusing on the truly obstructive aspects of BPH. Its unique anatomically shaped proprietary nitinol implant is positioned in the prostatic urethra in order to open the urine path in the prostate for improved urine flow thereby relieving BPH symptoms. The device comes in multiple sizes, and, unlike more invasive approaches, does not require any resection, cutting, or ablation of prostatic tissue.

The procedure can be completed with local anaesthesia in under ten minutes in the urologist’s office, with patients being able to get back to normal activities immediately. It is also completely reversible, with the device easily removed, ensuring patients can benefit from any future therapy, if necessary.

Results from clinical trials are very promising with blocked urethras successfully opened having an immediate and long term effect on patients’ quality of life.

“We are proud to bring a simple, non-surgical treatment option to the millions of men worldwide afflicted by BPH. Using the Butterfly Medical device, urologists can now provide treatment quickly and easily in their office,” said Idan Geva, CEO Butterfly Medical. Dr Shimon Eckhouse, Chairman of Butterfly added: “The minimally invasive, non-surgical device market for BPH treatment is a very active market with significant M&A deals in the range of a few hundred million to one billion dollars. Butterfly’s innovative solution has great potential to become a leading solution for this market.”

About Butterfly Medical

Butterfly Medical is a medical-device start-up, founded as part of Alon Medtech Ventures, owned by Dr Shimon Eckhouse. The company is developing a fast, simple, and minimally invasive alternative treatment to medication and surgery used for Benign Prostate Hyperplasia (BPH) treatment. Its innovative device transfers the procedure from the operating room to the clinic, with the device being placed in under 10 minutes, in-office, under local anaesthesia. Clinical trials performed in leading medical centres in Israel show a high degree of safety and effectiveness. Further, post-marketing studies are planned in leading medical centres in Europe, and a pivotal FDA study is planned in the US. For more information, see http://www.butterfly-medical.com.

Share article on social media or email:

Health

Applying Advanced Analytics to Overcome CNS Trial Challenges, Upcoming Webinar Hosted by Xtalks

Leave a comment


The increasing digitalization of research processes, and the resultant proliferation in electronic data generated, present new opportunities for research teams.


TORONTO (PRWEB)

Although the clinical research community invests substantial capital into developing new treatments for central nervous system (CNS) diseases, success remains elusive, with 85 percent to 99 percent of clinical trials failing to result in approval for new treatments. Reasons for the relatively low success rates are manyfold, but research in most CNS indications shares overlapping challenges, such as the subjective nature of clinician-reported outcome assessments on which many CNS endpoints are based, increasing placebo response, eligibility criteria, and burdensome requirements for sites or patients.

The increasing digitalization of research processes, and the resultant proliferation in electronic data generated, present new opportunities for research teams.

In this webinar, Signant’s clinical experts and guest panelists discuss data analytics approaches to improving CNS trial outcomes. Register for this topical, virtual event to learn how clinical and data science teams can collaboratively monitor and proactively manage endpoint data quality throughout a trial.

Featured topics will include:


  •     Managing data quality at sites

  •     Using artificial intelligence to identify at-risk raters

  •     Identifying appropriate, reliable participants in schizophrenia and early Alzheimer’s disease trials based on instrument data

Join Alan Kott, MDur, Practice Leader, Data Analytics, Signant Health; John Harrison, PhD, Principal Consultant, Metis Cognition Ltd.; and Colin Sauder, PhD, Director, Clinical Scientist, Karuna Therapeutics, for the live webinar on Tuesday, December 14, 2021 at 10am EST (3pm GMT/UK).

For more information, or to register for this event, visit Applying Advanced Analytics to Overcome CNS Trial Challenges.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

Health

Establishing Efficacy with Flow Cytometry-Based Receptor Occupancy Assays, Upcoming Webinar Hosted by Xtalks

Leave a comment


Reagent specificity is important as the assay relies on the ability to distinguish free vs. bound and total receptor.


TORONTO (PRWEB)

In clinical trials and drug development, receptor occupancy assays by flow cytometry are increasingly becoming the recommended method to establish efficacy of the targeted drug.

In this live webinar, hear from experienced scientists from Medpace’s central labs as they discuss how flow cytometric receptor occupancy assays — when correctly implemented — are a powerful tool in modelling pharmacokinetic/pharmacodynamic (PK/PD) relationships in the development of novel drugs.

Flow cytometric receptor occupancy assays can measure specific receptor occupancy and do so on different and specific cell sub-sets. In assay development, careful reagent selection is important to assure reliable receptor occupancy read out. Reagent specificity is important as the assay relies on the ability to distinguish free vs. bound and total receptor. Careful evaluation of the protocol is important to evaluate feasibility of reproducible protocol execution, which requires that the person performing the assay be highly qualified.

Join flow cytometry experts from Medpace, Priscillia Bresler, PhD, Scientist; and Andre Olsson, PhD, Senior Scientist, for the live webinar on Tuesday, December 14, 2021 at 10am EST (3pm GMT/UK) to learn about the benefits of flow cytometry-based receptor occupancy assays in clinical trials

For more information, or to register for this event, visit Establishing Efficacy with Flow Cytometry-Based Receptor Occupancy Assays.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

Health

Best Practice Considerations for the In Vivo QTc Core Assay, Upcoming Webinar Hosted by Xtalks

Leave a comment


Register for this webinar to understand how the in vivo QTc assay fits within the ICH guidelines, and how CV safety pharmacology study models are validated and verified.


TORONTO (PRWEB)

The goal of cardiovascular safety pharmacology is to evaluate the effects of test substances on the most relevant parts of the cardiovascular system, to detect potentially undesirable effects, before engaging in clinical trials.

ICH guidelines provide information regarding best practices when designing and executing preclinical safety pharmacology studies. The in vivo QTc assay is used by the pharmaceutical industry to characterize the potential for delayed ventricular repolarization and is a core safety assay mentioned in ICH S7B guideline.

The first segment of this webinar will focus on the specific components in the ICH guidelines and how to incorporate them into an IND-enabling cardiovascular telemetry study design. In the second segment of this webinar, they will discuss exposure-response (ER) analysis, or pharmacokinetic/pharmacodynamic (PK/PD) analysis of cardiovascular telemetry data. Concentration QTc (C-QTc) analysis has been proposed as a valid alternative to the conventional approach which combines PK exposure and PD response data. The speakers will also discuss power analysis (detection sensitivity) and its role in assessing study quality.

Register for this webinar to understand how the in vivo QTc assay fits within the ICH guidelines, and how CV safety pharmacology study models are validated and verified.

Join Ty Speece, BS, Safety Pharmacology, Inotiv; and Joel Baublits, MS, Director of Operations, Cardiovascular Analytics, for the live webinar on Monday, December 13, 2021 at 1pm EST.

For more information, or to register for this event, visit Cardiovascular Safety Pharmacology: Best Practice Considerations for the In Vivo QTc Core Assay.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

Health

MedVet Mahoning Valley Transitions to Urgent Care Facility to Better Serve Pets in the Mahoning Valley and Surrounding Community

Leave a comment


Opening an Urgent Care facility is one of the ways we are working to reduce wait times – making sure we deliver on our promise: providing exceptional care and service every day, every time, to everyone.


WORTHINGTON, Ohio (PRWEB)

MedVet has transitioned the MedVet Mahoning Valley location from an overnight and weekends emergency hospital to an Urgent Care as of Sunday, Nov. 21, 2021. The hospital will be open from 12:00 pm to 10:00 pm, 365 days a year, including holidays.

“We are committed to supporting pets and their loving families in the Mahoning Valley area and want to help them access quality care at the times they need it most,” said Dr. Jeff Brourman, MedVet’s Chief Growth Officer. “There’s an unmet need for care during more traditional, daytime hours as opposed to overnights. By converting a hospital that was only available nights and weekends to being available during peak times, we can better meet the needs of more pet owners, and our local veterinary community.”

Urgent Care offers patients a skillful evaluation of those unexpected, non-critical, non-life-threatening conditions such as allergies, bite wounds, diarrhea, ear infections, limping, lumps and bumps, toenail injuries, upper respiratory infections, urinary tract problems, vomiting, and more.

MedVet leaders believe helping their patients get in, get out, and get better more quickly in the Urgent Care will help address an ongoing trend that is being felt across the veterinary profession; namely, higher volumes and longer wait times. These circumstances are a continuing challenge for concerned pet owners and the veterinary professionals who are working tirelessly to provide care. MedVet Mahoning Valley is the second Urgent Care facility for MedVet with plans to open more locations in the next year.

“Opening an Urgent Care facility is one of the ways we are working to reduce wait times – making sure we deliver on our promise: providing exceptional care and service every day, every time, to everyone,” said Dr. Jim Vogt, MedVet Mahoning Valley’s Medical Director. “The same team that has been caring for pets at MedVet Mahoning Valley remains in place, providing the exceptional, well-coordinated care our patients and referral partners have come to rely upon.”

MedVet continues to serve family veterinarians in the area as an extension of the care they provide, creating a continuum of care supporting better patient outcomes. Pet owners should first contact their family veterinarian to determine if their pet can be seen and should continue to visit their family veterinarian for wellness and preventive care (such as vaccinations). MedVet Urgent Care provides care for patients who cannot be seen by their family veterinarian or who need the next level of care. The Mahoning Valley caregiver team will stabilize pets needing more advanced care for transport to MedVet Akron, MedVet Cleveland West, or MedVet Pittsburgh. These three nearby MedVet locations continue to provide 24/7 emergency, critical, and specialty care for life-threatening and advanced needs.

MedVet Urgent Care is located at 2680 W. Liberty St., Girard, Ohio, 44420. Pet owners can contact the facility at 330.530.8387 with any questions during operating hours.

About MedVet:

MedVet is the leading veterinarian owned and led family of specialty and emergency hospitals dedicated to delivering exceptional care and a deeply supportive experience to pets and their loving families, referring veterinarians, and team members. For more than 30 years, MedVet’s empathetic, insightful, and driven team of expert caregivers has helped the organization grow to be the preferred choice for high quality, compassionate care, proudly serving more than 400,000 patients each year in communities throughout the United States. To learn more about MedVet and its mission of Leading Specialty Healthcare for Pets, visit medvet.com. 

###

Share article on social media or email:

Society: Social Services

Allegheny Health Network Urban Health & Street Medicine, City of Pittsburgh Office of Community Health & Safety Partner to Open Three Community Outreach Hubs

Leave a comment


AHN Urban Health & Street Medicine team cuts ribbon to Community Outreach Hub in downtown Pittsburgh.

“Demonstrating the role that a health care system can play in community empowerment and linkage to care, the community outreach hubs will provide a dignified setting for engagement and continued supportive relationships between our teams and those with whom we work.”


PITTSBURGH (PRWEB)

Marking a significant next step in an ongoing partnership to provide more robust support services to individuals with unmet health and wellness needs in Pittsburgh communities, AHN’s Urban Health & Street Medicine program and the City of Pittsburgh’s Office of Community Health & Safety today announced plans to open three community outreach hubs across the City over the next several months. Officials cut the ribbon today to the first hub which is located in Downtown Pittsburgh at 538 Smithfield Street.

Since launching in the spring of 2021, the Urban Health & Street Medicine program’s three street outreach teams have worked with more than 1,000 unique individuals across Pittsburgh at the intersection of homelessness, substance use and untreated mental health issues. With the opening of these community outreach hubs, the AHN teams will have centralized spaces to follow up with and care for those individuals and others in the future.

“While working alongside community members who often face a range of barriers within the housing, health care and criminal legal systems, our teams have recognized the need for designated spaces – free of discrimination and stigma – in which individuals can receive care and assistance as they navigate these systems,” said Dan Palka, administrative director, Urban Health & Street Medicine at AHN’s Center for Inclusion Health. “Demonstrating the role that a health care system can play in community empowerment and linkage to care, the community outreach hubs will provide a dignified setting for engagement and continued supportive relationships between our teams and those with whom we work.”

AHN’s community outreach teams, which include trained professionals serving as homeless services team leads, outreach specialists and community health workers, will work at the hubs to connect individuals with social services and housing resources, and will assist them in accessing and navigating needed health care services. The hubs will not function as homeless shelters, soup kitchens or drop-in centers.

The community outreach teams receive clinical support from a variety of partners including Federally Qualified Health Centers (FQHCs), community behavioral health organizations, Allegheny County Health Department and the Center for Inclusion Health’s array of specialized health services. The hubs will provide a low-barrier engagement space for these partners’ vital services.

In addition to the location in Downtown Pittsburgh, which will operate on weekdays from 8:30 a.m. – 4:30 p.m., two other community outreach hubs will open in the North Side and in East Liberty in the coming weeks and months.

A novel component of the partnership between AHN and the City of Pittsburgh is a collaboration with first responders known as the co-responder model. Traditionally, public safety agencies respond to calls to address the needs of those experiencing homelessness, problematic substance use and/or unaddressed mental health issues. Now, AHN’s street outreach teams are available to co-respond to such calls when requested by police officers, effectively integrating real-time social services supports into the emergency response process. The AHN teams have responded to more than 500 calls from police for assistance to date.

The community outreach hubs will support the co-responder model by serving as a central station for individuals who might otherwise be charged for low-level offenses. In line with a concept known as ‘Law Enforcement-Assisted Diversion’ (LEAD), police officers may transport an individual to an outreach hub for case management and connection with upstream services, thereby preventing criminal legal involvement or incarceration.

The partnership between AHN and the City was initiated through ‘Coronavirus Aid, Relief, and Economic Security (CARES) Act’ funds that were awarded to AHN by the City. In June, Mayor William Peduto announced that the partnership would receive an additional $10 million in funding which will aid in the continued expansion of services to all six police zones across Pittsburgh.

“What Pittsburgh has done, through our partnership with Allegheny Health Network and creating the Office of Community Health and Safety, is design a unique model that addresses the needs of our communities and puts people first. We have plenty of incredible resources throughout our city, but this model addresses that we don’t have to wait for people to seek out resources, we can bring the resources they need to them. We are already providing co-responders with public safety personnel through the Urban Health and Street Medicine program, and these new community outreach hubs will be easily accessible and provide sustainable, individualized support and resources. I thank AHN and OCH&S for their leadership and commitment and we look forward to our continued partnership,” said Mayor William Peduto.

The AHN Urban Health & Street Medicine program is just the latest example of AHN’s and Highmark Health’s commitment to improving health equity in the greater western Pennsylvania region by addressing social determinants of health. Nearby the new AHN Community Outreach Hub is a 45,000-square-foot homeless shelter being constructed as a result of a partnership between Highmark Health, UPMC, PNC, the City of Pittsburgh and Allegheny County. The shelter is expected to open next year.

AHN’s Center for Inclusion Health, part of the AHN Medicine Institute, was formed in 2014 as one of the nation’s first comprehensive programs of its kind focused on meeting the health care needs of individuals in underserved or marginalized populations. Through a coordinated and compassionate care delivery model, and using evidence-based interventions, its programs address the obstacles that make it difficult for people to access care. This includes, but is not limited to, addiction, food insecurity, HIV/AIDS, homelessness, immigrant/refugee health and transgender health.

###

About Allegheny Health Network

Allegheny Health Network (AHN.org), a Highmark Health company, is an integrated healthcare delivery system serving the greater Western Pennsylvania region. The Network is composed of 14 hospitals, ambulatory surgery centers, Health + Wellness Pavilions, an employed physician organization, home and community-based health services, a research institute and a group purchasing organization. The Network provides patients with access to a complete spectrum of advanced medical services, including nationally recognized programs for primary and emergency care, cardiovascular disease, cancer care, orthopedic surgery, neurology and neurosurgery, women’s health, diabetes and more. AHN employs approximately 21,000 people, has more than 2,600 physicians on its medical staff and serves as a clinical campus for Drexel University College of Medicine and the Lake Erie College of Osteopathic Medicine.

Health

ProRehab Physical Therapy Announces Partnership with Dunn Physical Therapy

Leave a comment


News Image

This partnership allows for continued growth and career opportunities for our staff, all while keeping our patients healthy and happy. We can’t wait to see what the future brings!- Susan Dunn, CEO and Founder of Dunn Physical Therapy


LOUISVILLE, Ky. (PRWEB)

ProRehab Physical Therapy (ProRehab) is proud to announce its newest partnership with Dunn Physical Therapy (Dunn), a private and therapist-owned comprehensive pelvic health-focused Physical Therapy practice located in Louisville, Kentucky.

“My team and I have worked hard to grow Dunn over the past 20 years and we could not be more excited to continue this journey as part of the well-established ProRehab family,” said Susan Dunn, PT, WCS, CEO and Founder of Dunn. “This partnership allows for continued growth and career opportunities for our staff, all while keeping our patients healthy and happy. We can’t wait to see what the future brings!”

While patients will continue to see the same familiar faces at Dunn PT and offer the same pelvic programs, the clinical team will have greater access to the nationally recognized Physical Therapy education company, Evidence In Motion. This will allow the team to not only offer the same services but to improve them as well.

“We are excited to welcome Dunn into the ProRehab family,” says CEO of ProRehab, Pat Wempe, PT, DPT, SCS, CSCS. “Since opening our doors, our vision has been to positively impact the lives of patients by delivering the best care and results throughout all of our clinics and across Illinois, Indiana, and Kentucky. Our team is delighted that this partnership will allow us to continue this vision and reach more residents than before.”

This partnership makes 37 ProRehab clinics across Illinois, Indiana, and Kentucky, further expanding the group’s footprint.

Dunn Physical Therapy has two locations:


Louisville, KY 40207

  • 10321 Champion Farms Drive


Louisville, KY 40241

For more information about ProRehab please visit https://prorehab.com/. For more information about Dunn, or to meet with one of their expert therapists, please visit https://dunnptky.com/index.html.

###

About ProRehab Physical Therapy (PRPT):

ProRehab Physical Therapy (PRPT) is a Kentucky-based, private physical therapy practice group. As a proud member of the Confluent Health family, PRPT positively impacts patients’ lives by delivering the best care and results through proven research, innovative treatments and technologies, and an approach that treats patients like family. For more information, visit prorehab.com, or find them on Facebook at @prorehablou.

About Dunn Physical Therapy (Dunn PT):

Dunn Physical Therapy (Dunn PT) is a Kentucky-based, private physical therapy practice group that offers comprehensive pelvic health services to its patients. As a proud member of the Confluent Health family, Dunn PT positively impacts patients’ lives by delivering the best care and results through proven research, innovative treatments and technologies, and an approach that treats patients like family. For more information, visit dunnptky.com.com, or find them on Facebook at @DunnPTKY.

Share article on social media or email:

Health

Researcher Awarded 2021 Strategic Radiology/RSNA Research Grant

Leave a comment


Vijay Rao, MD, Chair, RSNA R&E Foundation Board of Trustees

Because of the generous investment made by Strategic Radiology, the R&E Foundation can continue to advance innovative radiology research and education efforts across medicine; it is this commitment that will strengthen and sustain the specialty.


OAK BROOK, Ill. (PRWEB)

The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation awarded the 2021 Strategic Radiology/RSNA Research Seed Grant to Edward Kuoy, M.D. This grant is made possible by Strategic Radiology’s support of the RSNA R&E Foundation.

The Strategic Radiology/RSNA Research Seed Grant provides $40,000 for a one-year project, enabling investigators to gain experience in defining objectives and testing hypotheses in preparation for major grant applications to corporations, foundations, and governmental agencies.

Edward Kuoy, M.D., University of California, Irvine, will perform a prospective cohort study evaluating the downstream operational and clinical impacts of point of care (POC)-MRI in the Emergency Department (ED) and Intensive Care Unit (ICU) settings. Noting that POC-MRI lowers the barrier to MRI, Dr. Kouy’s research aims to determine if this immediate access to MRI improves operational efficiencies and/or clinical outcomes.

In 2021, the R&E Foundation Board of Trustees approved $3.2 million in grant funding support for 80 individuals at 40 institutions. “Because of the generous investment made by Strategic Radiology, the R&E Foundation can continue to advance innovative radiology research and education efforts across medicine; it is this commitment that will strengthen and sustain the specialty. The Board of Trustees expresses its sincerest appreciation for Strategic Radiology’s partnership in funding radiology’s future and is grateful for this steadfast commitment,” said Vijay M. Rao, M.D., Chair of the RSNA R&E Foundation Board of Trustees.

The 2021 grant represents the third of 20 grants that will be distributed annually through 2038. “We are honored to be able to support the important work of the RSNA R&E Foundation,” said Scott Bundy, MD, FACR, CEO and Chair, Strategic Radiology. “Dr. Kuoy’s research has the potential to expand access to time-sensitive, life-changing treatments in the acute setting by offering cost-effective and efficient point-of-care diagnoses.”

About RSNA

RSNA is an association of radiologists, radiation oncologists, medical physicists and related scientists promoting excellence in patient care and health care delivery through education, research and technologic innovation. The Society is based in Oak Brook, Ill. (RSNA.org)

The mission of the RSNA R&E Foundation is to improve patient care by supporting research and education in radiology and related scientific disciplines through funding grants and awards to individuals and institutions that will advance radiologic research, education and practice. RSNA.org/Foundation

About Strategic Radiology    

Strategic Radiology is a coalition of 30+ privately owned, independent, radiology practices with a national footprint, representing 1300+ radiologists that have come together to improve quality, gain operational efficiencies, and innovate the future of radiology’s private practice model. Strategic Radiology engages in triannual membership and board meetings, including executive and leadership education as well as bi-annual meetings of the SR–Patient Safety Organization (PSO), the nation’s first radiology-specific PSO listed by the Agency for Healthcare Research and Quality. SR also provides its member groups value through shared savings via a group purchasing program and strategic partnerships.

http://www.StrategicRadiology.org.

SR Members:

  • ARA Health Specialists; Asheville, NC

  • Casper Medical Imaging and Outpatient Radiology; Casper, WY

  • Central Illinois Radiological Associates; Peoria, IL

  • Chesapeake Medical Imaging; Annapolis, MD

  • Delaney Radiology; Wilmington, NC

  • Diagnostic Imaging Northwest; Portland, OR

  • Gaston Radiology; Gastonia, NC

  • The Hill Medical Corporation; Pasadena, CA

  • Huron Valley Radiology; Ann Arbor, MI

  • Inland Imaging; Spokane, WA

  • Mecklenburg Radiology Associates; Charlotte, NC

  • Medical Center Radiology Group; Orlando, FL

  • Modesto Radiological Medical Group (MRMG); Modesto, CA

  • Mountain Medical Physician Specialists; Salt Lake City, UT

  • Naugatuck Valley Radiological Associates; Waterbury, CT

  • Northwest Radiology; Indianapolis, IN

  • Quantum Radiology; Atlanta, GA

  • Radiologic Medical Services; Iowa City, IA

  • Radiology Associates; Jeffersonville, IN

  • Radiology Associates; Corpus Christi, TX

  • Radiology Associates of Macon; Macon, GA

  • Radiology Associates of Nevada; Las Vegas, NV

  • Radiology Associates of North Texas; Dallas/Fort Worth, TX

  • Radiology Associates of Richmond; Richmond, VA

  • Radiology Associates of Tallahassee; Tallahassee, FL

  • Rome Radiology Group; Rome, GA

  • Southeast Radiology, Ltd.; Glen Mills, PA

  • Tower Imaging Medical Group; Santa Monica, CA

  • Triad Radiology Associates; Winston-Salem, NC

  • United Imaging Consultants; Mission, KS

  • X-Ray Consultants; South Bend, IN

Share article on social media or email:

health and fitness

Buy 2 Get 1 Free On All Cannabinoid Tinctures And Gummies + Free CBD, CBG, CBN, THCV Gummies

Leave a comment


THCV-Delta-8-THC-CBN-CBG-Gummies-Rare-Cannabinoid

Black Friday Deal: Customers can choose any three products and receive the least expensive free. They will also receive free CBD, CBG, CBN and THCV gummies with a $50 purchase.

Our new Gummies Variety Packets make the perfect stocking stuffers, and, since deals can be combined, we’re seeing customers stocking up on their favorite cannabinoids and getting lots of free items for gifts.


HONOLULU (PRWEB)

Rare Cannabinoid Company announces its best-ever Black Friday Deal: Buy two get one free on its entire apothecary of cannabinoids: THCV, CBDV, Delta-8-THC, CBDA, CBC, CBG, CBN, full spectrum Hawaiian CBD, terpenes and extra strength cannabinoid gummies. In addition, customers can try all of their new CBD, CBG, CBN, and THCV gummies for free when they spend $50 or more. Shop Black Friday Hemp Deals now.

The Hawaiian company’s sister-brand Hawaiian Choice CBD is also offering a similar Black Friday buy 2 get 1 free deal and special offer freebies on their real fruit pineapple-passion CBD jellies. Buy Hawaiian CBD here.

Rare Cannabinoid Company sells more cannabinoids than any other brand and was the first to offer single extracts of THCV and CBDV for sale, terpene-only blends and has the strongest THCV gummies. Whether one is looking for help losing weight, improving their mood, or falling asleep at night, they have a tincture or gummy that can help. Plus, their gummies make excellent gifts.

“Our new Gummies Variety Packets make the perfect stocking stuffers, and, since deals can be combined, we’re seeing customers stocking up on their favorite cannabinoids and getting lots of free items for gifts,” said Jennifer Carlile, Rare Cannabinoid Company Co-Founder and Creative Director.

Here’s how Rare Cannabinoid Company’s deals work:

Buy 2 Get 1 FREE: Buy any three Rare Cannabinoid Company products – mix and match single extracts, ready blends, terpene-only tinctures, or cannabinoid gummies – and you’ll receive the least expensive one free.

Spend $50, Get FREE Gummies: Rare Cannabinoid Company just launched the world’s first high potency mix-and-match CBD, CBN, CBG and THCV gummies. For any order of $50 or more, customers will receive a free Variety Packet of Gummies. It contains one 25mg lemon THCV gummy, one 30mg huckleberry CBN gummy, one 30mg green apple CBG gummy, and three 30mg strawberry CBD gummies.

Yes, both Black Friday Deals can be combined: This means that customers can choose any three products – for example, a THCV tincture for energy and appetite control in the morning, a CBG tincture for soreness and discomfort, and a bottle of CBN gummies to help them fall asleep at night. With this combination, the pure CBG tincture is the least expensive item and will be free. Since the customer will have spent more than $50, they will also receive the packet of gummies for free.

Not sure what to buy? Rare Cannabinoid Company recently redesigned its website so that customers can now shop by need and easily find the perfect combination for any of the following needs: Energy and Focus, Sleep, Stress Relief, Discomfort, Mood Enhancers, Appetite Suppression, or Nausea.

The company believes that rare cannabinoids work best when added to full spectrum CBD or a broad spectrum CBD for the entourage effect. Each rare cannabinoid offers unique mental and physical effects which is why they should be combined for different needs. These needs and cannabinoid combinations can differ depending on time of day the person’s physiological state.

Each product page offers a list of links to scientific and medical research on each cannabinoid. Here’s a brief summary of what each cannabinoid is frequently taken for:

THCV (tetrahydrocannabivarin): Acts like a stimulant, as it increases energy and suppresses hunger, shows promise in reducing the risk of type 2 diabetes, anxiety and panic attacks, and addiction to nicotine.

CBN (cannabinol): May promote rest, relaxation, sleep, and is believed to be more strongly sedative than other cannabinoids, especially when combined with delta-8 THC and relaxing terpenes.

Delta-8 THC (delta-8-tetrahydrocannabinol): Relieves discomfort and nausea. Offers similar effects to delta-9-THC with less risk of anxiety or paranoia.

CBC (cannabichromene): Best non-psychoactive cannabinoid for improving mood as it raises levels of the brain’s bliss chemical “anandamide.”

CBDA (cannabidiolic acid): Reduces nausea and may in reduce inflammation from daily exercise and activities.

CBD (cannabidiol): Promotes stress resilience, a sense of calm, and may reduce inflammation from daily activities.

CBDV (cannabidivarin): May reduce swelling from daily activities and nausea and is being studied for use in people with autism spectrum disorder, muscular dystrophy, seizures, and other disorders.

CBG (cannabigerol): May offer relief from discomfort and is being studied for use against many ailments.

Relax Terpenes: Blend of myrcene, pinene, carene, limonene, and linalool designed to promote rest, relaxation, and sleep especially when combined with cannabinoids.

Relief Terpenes: Blend of pinene, limonene, linalool, caryophyllene designed to reduce pain, inflammation, and stress especially when combined with cannabinoids.

Rare Cannabinoid Company is an American company based in the 50th state of Hawaii. It was established in the first quarter of 2020 and is a pioneer in the “rare” or “minor” cannabinoid industry, offering purified tinctures and gummies of rare cannabinoid and terpenes as well as blends with full spectrum Hawaiian CBD. Its products are sold in more than 200 locations across the United States and by prescription in Brazil.

Rare Cannabinoid Company is the sister brand of Hawaiian Choice, which was established in the fourth quarter of 2017. Hawaiian Choice is a luxury, lifestyle brand that combines premium broad spectrum Hawaiian CBD with organic and wild crafted Hawaiian fruits, essential oils and honey in an assortment of tinctures, edible jellies, topical gels, and pet products. Its products are also sold in more than 200 locations from New York to Tokyo to the Mariana Islands.

Stores interested in stocking Rare Cannabinoid Company and/or Hawaiian Choice products can request a wholesale account at Wellness Orders.

Society: Christianity

Every Tear Counts” is an inspiring collection of personal reflections based on the author’s faith

Leave a comment


News Image


MEADVILLE, Pa. (PRWEB)

“Calculated Blessings: Every Tear Counts”: a thoughtful and encouraging discussion of life and faith. “Calculated Blessings: Every Tear Counts” is the creation of published author Evangela C. W. Jeffrey, a native of Washington, D.C. who currently resides in Maryland.

Jeffrey shares, “With a new decade of my life quickly approaching, it is time to write the next chapter. With my main focus in life being geared toward encouraging, empowering, and enriching the lives of others, I have neglected to fully apply these principles to my own life. I want to walk in my destiny and next chapter with boldness and courage. My faith will be the shield to protect me from fear, doubt, and defeat. My positivity keeps me excited, and I live in expectation every day!

“Many, O LORD my God, are thy wonderful works which thou hast done, and thy thoughts which are to us-ward: they cannot be reckoned up in order unto thee: if I would declare and speak of them, they are more than can be numbered. (Psalm 40:5)”

Published by Christian Faith Publishing, Evangela C. W. Jeffrey’s new book invites readers to step back and evaluate their current position on faith and seek a deeper connection with Christ.

Jeffrey shares a hopeful and personal discussion within the pages of this empowering work.

Consumers can purchase “Calculated Blessings: Every Tear Counts” at traditional brick & mortar bookstores, or online at Amazon.com, Apple iTunes store, or Barnes and Noble.

For additional information or inquiries about “Calculated Blessings: Every Tear Counts,” contact the Christian Faith Publishing media department at 866-554-0919.

Share article on social media or email: